These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2865112)

  • 21. Pharmacokinetics of Sulindac.
    Kwan KC; Duggan DE
    Acta Rhumatol Belg; 1977; 1(3-4):168-78. PubMed ID: 756665
    [No Abstract]   [Full Text] [Related]  

  • 22. Dimethyl sulfoxide inhibits bioactivation of sulindac.
    Swanson BN; Boppana VK; Vlasses PH; Rotmensch HH; Ferguson RK
    J Lab Clin Med; 1983 Jul; 102(1):95-101. PubMed ID: 6854139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enterohepatic circulation of methotrexate in rats in vivo.
    Steinberg SE; Campbell CL; Bleyer WA; Hillman RS
    Cancer Res; 1982 Apr; 42(4):1279-82. PubMed ID: 7060005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term diabetes alters the hepatobiliary clearance of acetaminophen, bilirubin and digoxin.
    Watkins JB; Sherman SE
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1337-43. PubMed ID: 1545396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulindac metabolism: the importance of an intact colon.
    Strong HA; Warner NJ; Renwick AG; George CF
    Clin Pharmacol Ther; 1985 Oct; 38(4):387-93. PubMed ID: 4042521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The roles of renal catabolism and uremia in modifying the clearance of fibrinogen and its degradative fragments D and E.
    Iio A; Rutherford WE; Wochner RD; Spilberg I; Sherman LA
    J Lab Clin Med; 1976 Jun; 87(6):934-46. PubMed ID: 932524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ibuprofen and sulindac kinetics in alcoholic liver disease.
    Juhl RP; Van Thiel DH; Dittert LW; Albert KS; Smith RB
    Clin Pharmacol Ther; 1983 Jul; 34(1):104-9. PubMed ID: 6861431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A kinetic study of sulindac in the elderly.
    Bayley N; Warne RW; Moulds RF; Bury RW
    Aust N Z J Med; 1987 Feb; 17(1):39-42. PubMed ID: 3476045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulindac oxidation/reduction by microbial cultures; microbial models of mammalian metabolism.
    Davis PJ; Guenthner LE
    Xenobiotica; 1985 Oct; 15(10):845-57. PubMed ID: 4072250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulindac disposition when given once and twice daily.
    Swanson BN; Boppana VK; Vlasses PH; Holmes GI; Monsell K; Ferguson RK
    Clin Pharmacol Ther; 1982 Sep; 32(3):397-403. PubMed ID: 7049504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics of biliary elimination of pentacaine in rats.
    Bezek S; Scasnár V; Kukan M; Trnovec T
    Biopharm Drug Dispos; 1990 Jul; 11(5):403-9. PubMed ID: 2207294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of uraemia and anephric state on the pharmacokinetics of tenoxicam in the rat.
    Lopez-Bustamante LG; Troconiz JI; Fos D
    J Pharm Pharmacol; 1992 Nov; 44(11):898-901. PubMed ID: 1361533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and dialyzability of sulindac and metabolites in patients with end-stage renal failure.
    Ravis WR; Diskin CJ; Campagna KD; Clark CR; McMillian CL
    J Clin Pharmacol; 1993 Jun; 33(6):527-34. PubMed ID: 8366178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired biliary excretion of taurocholate associated with increased biliary tree permeability in mirex- or chlordecone-pretreated rats.
    Curtis LR; Hoyt D
    J Pharmacol Exp Ther; 1984 Dec; 231(3):495-501. PubMed ID: 6209385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biliary excretion of organic anions in diabetic rats.
    Watkins JB; Noda H
    J Pharmacol Exp Ther; 1986 Nov; 239(2):467-73. PubMed ID: 2430094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of sulindac and its metabolites on acute stress-induced gastric ulcers in rats.
    Glavin GB; Sitar DS
    Toxicol Appl Pharmacol; 1986 Apr; 83(2):386-9. PubMed ID: 3961821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of the biliary pathway to the homeostasis of vitamin D3 and of 1,25-dihydroxyvitamin D3.
    Gascon-Barré M; Gamache M
    Endocrinology; 1991 Nov; 129(5):2335-44. PubMed ID: 1657572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of metabolism in the biliary excretion of methadone metabolites.
    Roerig DL; Hasegawa AT; Wang RI
    J Pharmacol Exp Ther; 1976 Oct; 199(1):93-102. PubMed ID: 978487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of castration and treatment with testosterone on the biliary excretion of (3H)aldosterone in rats.
    Morris DJ; DeConti GA
    Endocrinology; 1976 Aug; 99(2):476-80. PubMed ID: 954647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membrane effects of antiinflammatory agents. 1. Interaction of sulindac and its metabolites with phospholipid membrane, a magnetic resonance study.
    Fan SS; Shen TY
    J Med Chem; 1981 Oct; 24(10):1197-202. PubMed ID: 6276543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.